S744 QUASAR Induction Study 1 Cumulative Response to Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis. (October 2022) - Rubin, David T.; Lichtenstein, Gary; Shipitofsky, Nicole; Huang, Kuan-Hsiang; Germinaro, Matthew; Wilson, Rebbecca; Zhang, Hongyan; DuVall, Aaron; Cao, Qian; Allegretti, Jessica R.; Feagan, Brian G.; Peyrin-Biroulet, Laurent; et al.